Emerging drugs for major depressive disorder

Escitalopram in the treatment of major depressive disorder: A meta-analysis

(2009) Sidney H. Kennedy et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression)

(2009) George I. Papakostas et al.   JOURNAL OF CLINICAL PSYCHIATRY

Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy

(2009) Kuan-Pin Su et al.   JOURNAL OF CLINICAL PSYCHIATRY

Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder

(2009) Karl Rickels et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effects of PRX-00023, a Novel, Selective Serotonin 1A Receptor Agonist on Measures of Anxiety and Depression in Generalized Anxiety Disorder

(2009) Karl Rickels et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

(2009) Andrea Cipriani et al.   LANCET

Pathophysiology of depression: Role of sleep and the melatonergic system

(2009) Venkataramanujan Srinivasan et al.   PSYCHIATRY RESEARCH

A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH1Antagonist) in the Treatment of Major Depression

(2008) Brendon Binneman et al.   AMERICAN JOURNAL OF PSYCHIATRY

Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder

(2008) Shima Jazayeri et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise

(2008) Catharine H. Duman et al.   BEHAVIOURAL BRAIN RESEARCH

Clinical Pharmacogenetics and Potential Application in Personalized Medicine

(2008) Shu-Feng Zhou et al.   CURRENT DRUG METABOLISM

Psychotropic prescription practices in east Asia: looking back and peering ahead

(2008) Chay-Hoon Tan et al.   CURRENT OPINION IN PSYCHIATRY

Central CRH system in depression and anxiety — Evidence from clinical studies with CRH1 receptor antagonists

(2008) Florian Holsboer et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects

(2008) M.E. Breuer et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder

(2008) María Eugenia Hernández et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Circadian rhythm disturbances in depression

(2008) Anne Germain et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR

(2008) Sidney H. Kennedy et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Nicotinic Antagonist Augmentation of Selective Serotonin Reuptake Inhibitor-Refractory Major Depressive Disorder

(2008) Tony P. George et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder

(2008) Sheldon H. Preskorn et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia

(2008) Peter Gallagher et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Cross-Talk between Dopaminergic and Noradrenergic Systems in the Rat Ventral Tegmental Area, Locus Ceruleus, and Dorsal Hippocampus

(2008) B. P. Guiard et al.   MOLECULAR PHARMACOLOGY

Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons

(2008) Alessia Bachis et al.   NEUROPHARMACOLOGY

Novel Drugs and Therapeutic Targets for Severe Mood Disorders

(2008) Sanjay J Mathew et al.   NEUROPSYCHOPHARMACOLOGY

Effects of the β3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: Relevance to its antidepressant/anxiolytic-like profile

(2008) Y. Claustre et al.   NEUROSCIENCE

Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis

(2008) Barbara Segal et al.   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial☆

(2008) Jon I. Russell et al.   PAIN

Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression

(2008) Anteneh M. Feyissa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

New Onset Depression Following Myocardial Infarction Predicts Cardiac Mortality

(2008) Chris Dickens et al.   PSYCHOSOMATIC MEDICINE

Comorbid depression in rheumatoid arthritis: Pathophysiology and clinical implications

(2008) Travis O. Bruce   Current Psychiatry Reports

Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs

(2007) Charles B. Nemeroff et al.   BIOLOGICAL PSYCHIATRY

Effects of sibutramine and orlistat on mood in obese and overweight subjects: A randomised study

(2007) D.N. Kiortsis et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

(2007) Daniel Tracey et al.   PHARMACOLOGY & THERAPEUTICS

Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models

(2007) Caroline Louis et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR